Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) shares, rose in value on Tuesday, December 31, with the stock price up by 1.14% to the previous day’s close as strong demand from buyers drove the stock to $4.43.
Actively observing the price movement in the last trading, the stock closed the session at $4.38, falling within a range of $4.36 and $4.51. The value of beta (5-year monthly) was 0.475. Referring to stock’s 52-week performance, its high was $15.70, and the low was $3.06. On the whole, IRWD has fluctuated by 25.85% over the past month.
With the market capitalization of Ironwood Pharmaceuticals Inc currently standing at about $717.02 million, investors are eagerly awaiting this quarter’s results, scheduled for in February.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that IRWD’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of IRWD currently trading nearly 13.36% and 10.76% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 60.08, while the 7-day volatility ratio is showing 5.29% which for the 30-day chart, stands at 9.49%. Furthermore, Ironwood Pharmaceuticals Inc (IRWD)’s beta value is 0.35, and its average true range (ATR) is 0.34.
A comparison of Ironwood Pharmaceuticals Inc (IRWD) with its peers suggests the former has fared considerably weaker in the market. IRWD showed an intraday change of 1.14% in last session, and over the past year, it shrunk by -61.28%%.
Data on historical trading for Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) indicates that the trading volumes over the past 10 days have averaged 2.85 and over the past 3 months, they’ve averaged 1.74 million. According to company’s latest data on outstanding shares, there are 160.02 million shares outstanding.
Nearly 2.66% of Ironwood Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 103.18% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 12.08 million shares as on 2024-12-13, resulting in a short ratio of 6.67. According to the data, the short interest in Ironwood Pharmaceuticals Inc (IRWD) stood at 1460.00 of shares outstanding as of 2024-12-13; the number of short shares registered in 2024-11-15 reached 8.57 million. The stock has fallen by -61.28% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IRWD stock heading into the next quarter.
